Primary Care: Clinics in Office Practice 1996: Vol 23 Index

19 Pages·1996·3.6 MB·English

CUMULATIVE INDEX 1996
Volume 23
March MODELS OF AMBULATORY CARE, pages 1-202
June ORTHOPEDICS, pages 203-415
September GASTROENTEROLOGY, pages 417-656
December COMMUNITY-ACQUIRED RESPIRATORY INFECTIONS IN
CHILDREN, pages 657-911
Note: Page numbers of article titles are in boldface type
Abdominal distention, from intestinal gas, cost issues and, 73-74
626-627 discussions on, 78-79
Abdominal pain, in irritable bowel syn- document for, 78-79
drome, 477, 480 durable power of attorney in, 69-70
Abductor pollicis longus tenosynovitis implementation of, barriers to, 75-78
(de Quervain’s syndrome), 310-311 laws on, 74
Abscess, lung, in pneumonia, 829, 833 legal repercussions and, 77
pancreatic, 529 patient beliefs about, 68-71
perirectal, 614-615 physician beliefs about, 71-72
peritonsillar (quinsy), 751-754 AIDS. See Human immunodeficiency virus in-
retropharyngeal, 747-751 fection.
Acanthosis nigricans, in gastrointestinal Airway maintenance, in epiglottitis, 745-
cancer, 465-466 746
Acetaminophen, in common cold, 671 Alanine aminotransferase, elevated, in hep-
Achalasia, dysphagia in, 429-430 atitis C, 538
Achilles tendon, rupture of, 293 measurement of, in liver disease screen-
tendinitis of, 275 ing, 552-553
Acid laryngitis, 434 Albumin, measurement of, in liver disease
Acquired immunodeficiency syndrome. See screening, 555
Human immunodeficiency virus infec- Albuterol, in bronchiolitis, 813
tion. Alcohol use and abuse, in homeless popu-
Acromioclavicular joint separation, trau- lation, 21-22, 24
matic, 384-385 liver disease in, vs. hepatitis C, 542
Acyclovir, in herpes simplex virus infec- pancreatitis from, 526-527
tions, anal, 618-619 Alkaline phosphatase, measurement of, in
Adenomatous polyps, gastrointestinal, cu- liver disease screening, 553-554
taneous manifestations of, 455-456 Allergy, otitis media in, 677-678
Adenovirus infections, common cold, 660—- pharyngitis in, 735-736
661, 665-667 sinusitis in, 703
pharyngitis, 724 ALT. See Alanine aminotransferase.
pneumonia, 840-841, 852 Amantadine, in common cold, 670
Adhesive capsulitis, 371, 373, 375-376 in pneumonia, 843
Adolescents, homosexuality in, 39 Ambulatory care, advance directives in,
humor with, 150-151 67-82
pregnancy in, community-oriented care community-oriented, 1-15
approach to, 9 cost considerations in, 115-126
Adrenergic agonists, in croup, 772 for homeless persons, 17-30
Advance directives, 67-82 for homosexual persons and families, 31-
cardiopulmonary resuscitation efficacy 46
and, 72-73 house call training program in, 47-65
changing preferences in, 69 humor in, 141-154
893
894 CUMULATIVE INDEX 1996
Ambulatory care (continued) Anxiolytics, in irritable bowel syndrome,
mind-body relationships in, 169-182 488
new paradigm for, 183-198 Aphthous ulcers, in inflammatory bowel
nurse practitioner collaboration in, 103- disease, 464
113 Apnea, in bronchiolitis, 809
preventive, 127-140 Apprehension and apprehension suppres-
specialty selection and, 155-167 sion tests, in shoulder evaluation,
telephone in, 83-102 370
Aminosalicylates, in inflammatory bowel Arcanobacterium haemolyticus infections,
disease, 577-584 pharyngitis, 733
Amoxicillin, in Helicobacter pylori infections, Aristotle, on health and disease, 186
449-450 Arterial occlusive disease, of foot, 207-208
in otitis media, 680-683 Arthritis, 215-240
in pharyngitis, 729-730 degenerative (osteoarthritis), 224-228,
in sinusitis, 710-711 380
Ampicillin, in diarrhea, 643 evaluation of, 216-224
Amylase, measurement of, in pancreatitis, history in, 216-218
527 imaging in, 223
Anaerobic infections, pharyngitis, 733 laboratory tests in, 222-223
Anal disease, 609-620 physical examination in, 218-221
abscesses, 614-615 radiography in, 222
examination in, 609-610 gouty, 232-234
fissures, 613-614 management of, initial, 223-224
fistulas, 615 of shoulder, 379-381
hemorrhoids, 610-613 pyogenic, 234-238, 381
incontinence, 616-617 rheumatoid, 228-232, 380
pruritus, 615-616 terminology of, 215
sexually transmitted, 617-619 Asclepios, representing patient-focused
Anger, management of, humor in, 144-146 medicine, 186
Angioma, spider, in liver disease, 469 Aspartate aminotransferase (AST, SGOT),
Ankle injuries, in running and walking. See measurement of, in liver disease
Running and walking. screening, 552-553
proprioception deficits in, 390-391 Aspiration, in gastroesophageal reflux dis-
rehabilitation in, 389-393 ease. See Gastroesophageal reflux dis-
ease, respiratory complications of.
sprains, 292-293
Aspirin, in common cold, 671
strength assessment in, 390
Asthma, in gastroesophageal reflux disease,
vs. normal function, 390
434-435, 564, 568
Antacids, in gastroesophageal reflux dis-
persistent cough in, 870, 884, 887
ease, 570
Athlete’s foot, 205
Antibiotics, in croup, 772-773, 779
Atropine, in diarrhea, 642
in diarrhea, 643
Autoimmune hepatitis, vs. hepatitis C, 540-
in otitis media, 679-684
541
in pneumonia, 830-833
Autonomic function, biofeedback control
in pyogenic arthritis, 236-237
of, 176-177
in sinusitis, 709-712
Autonomy, in medical decisions, 69
Antibodies, formation of, in common cold,
Azathioprine, in inflammatory bowel dis-
664
ease, 588-595
Anticholinergics, in diarrhea, 642
Azithromycin, in otitis media, 681-682
in irritable bowel syndrome, 485
in pharyngitis, 730
Antidepressants, in irritable bowel syn-
in sinusitis, 712
drome, 486-487
Antidiarrheal agents, 641-642
Antihistamines, in common cold, 670-671 Back pain, 345-364
in sinusitis, 713 chronicity of, 345-346
a,2-Antitrypsin, measurement of, in liver etiology of, 346-348
disease screening, 556 evaluation of, history in, 348-350
Antiviral drugs, in common cold, 670 imaging in, 351-353
Anxiety, relief of, humor in, 143-144, 148- physical examination in, 350-351
150 in disc herniation, 358-362
CUMULATIVE INDEX 1996 895
in insufficiency fracture, 358 Bradykinin, in common cold pathogenesis,
in osteomyelitis, 362-363 663
in spinal stenosis, 354-356 Brain, immune system interactions with,
in spondylolisthesis, 356-357 171-172
in tumors, 362 Bronchiolitis, 805-819
incidence of, 345 causes of, 805
mechanical, 353-354 clinical features of, 809-810
pathophysiology of, 346-348 diagnosis of, 810-811
referred, 364 epidemiology of, 805-806
Barium swallow, in gastroesophageal re- outcome of, 815-816
flux disease, 566 pathophysiology of, 806-809
Barrett’s esophagus, dysphagia in, 428 prevention of, 814-815
in gastroesophageal reflux disease, 565 treatment of, 811-814
Barriers, to health care, in homeless popu- Bronchitis, acute, 780-784
lation, 19-22 chronic, 781
Baths, contrast, in rehabilitation, 336-337 persistent cough in, 885
Beano, for flatulence, 625 recurrent, 781
Behavior, changes in, model for, 127-129 Bronchodilators, in bronchiolitis, 812-813
immune system effects of, 170-171 Bronze diabetes, vs. hepatitis C, 543
Behavioral therapy, in irritable bowel syn- Budesonide, in inflammatory bowel dis-
drome, 488-489 ease, 586
Belching, 622-624 Bulk-forming agents, in diarrhea, 642
Bentiromide test, for pancreatitis, 531 Bunions, 293-297
Benzodiazepines, in irritable bowel syn- Bursitis, of shoulder, 366
drome, 488
Biceps tendinitis, 376-378
Bichloroacetic acid, in condyloma acumi- Calcific tendinitis, of shoulder, 378-379
nata, 618 Calcification, of soft-tissue tumors, 247
Bile sequestrants, in diarrhea, 642 Calculi, gallbladder. See Gallstones.
Biliary cirrhosis, vs. hepatitis C, 543 Callouses, of foot, 203-204
Biliary colic, from gallstones, 501-502, 508- Campylobacter-like organism test, in Helico-
509 bacter pylori infections, 445-446
Biliary tract, scintigraphy of, in gallstones, Canada-Cronkhite syndrome, cutaneous
507 manifestations of, 456
stones in. See Gallstones. Cancer, gastrointestinal. See also Colorectal
Bilirubin, measurement of, in liver disease cancer.
screening, 557-559 cutaneous manifestations of, 465-467
Biofeedback, 176-177 in homosexual persons, 36-37
Biophysiosocial model, of medicine, 183— psychoneuroimmunology of, 173-174
185 screening for, in Home Visit Program,
Biopsy, liver, in hepatitis C, 539 61-62
soft-tissue tumors, 252 Capsulitis, adhesive, 371, 373, 375-376
Bisexual persons, 33-34 Carcinoid syndrome, cutaneous manifesta-
definition of, 31-32 tions of, 466
family of, 32 Carcinoma, esophageal, dysphagia in, 428-
Bismuth compounds, in diarrhea, 643 429
in Helicobacter pylori infections, 449-450 Cardiopulmonary resuscitation, efficacy of,
Bleeding, gastrointestinal, cutaneous mani- advance directives and, 70, 72-73
festations of, 459-464 Carisoprodol, as muscle relaxant, 329, 331
Bloating, in irritable bowel syndrome, 477 Carpal tunnel syndrome, 314-317
Blood culture, in pneumonia, 824-825 Carriers, of group A streptococci, 730-731
Blue rubber bleb nevus syndrome, in gas- Cauda equina syndrome, 350
trointestinal disease, 459-460 Cavus foot, 212, 264-265
Bone scan, in arthritis, 223 Cellular immune response, in common
Bordetella pertussis infections. See Pertussis. cold, 664
Borreliosis, pharyngitis in, 733 Cellulitis, in sinusitis, 714
Bowleg, 301 retropharyngeal, 747-751
Braces, in rehabilitation, 337-338 Central nervous system, altered perception
Brachial plexus injury, shoulder pain in, in, in irritable bowel syndrome, 480-
386 481
896 CUMULATIVE INDEX 1996
Cephalosporins, in otitis media, 681-682 Colic, biliary, from gallstones, 501-502,
in pharyngitis, 730 508-509
in sinusitis, 711-712 Colitis, diversion, treatment of, 597
Cervical radiculopathy, shoulder pain in, left-sided, treatment of, 601
ulcerative. See Ulcerative colitis.
Charcot foot, 213-214 Collaborative practice, with nurse practi-
Charcot’s triad, in cholangitis, from gall- tioners, 103-113
stones, 504-506 Colon, adenomatous polyps of, cutaneous
Charges, versus costs, 116-117 manifestations of, 455-456
Chemical mediators, in common cold, 663 fluid balance in, 630-631
Chemotherapy, for soft-tissue tumors, 256 Colonoscopy, in colorectal cancer screen-
Chenodeoxycholic acid, in gallstone disso- ing, 521-523
lution, 509 Colorectal cancer, screening for, 515-523
Chickenpox, pneumonia in, 841-842 colonoscopy in, 521-523
Chinese medicine, 186-187 examination in, 516-517
Chlamydial infections, anorectal, 619 history in, 515-516
pharyngitis, 733 polyp discovery during, 520-521
pneumonia, 846-847, 850-851, 856 polypectomy after, 522-523
Chloramphenicol, in diarrhea, 643 sigmoidoscopy in, 517-520
Cholangitis, from gallstones, 504-506 surveillance after, 523
sclerosing, vs. hepatitis C, 543 Common cold, 657-675
Cholecystectomy, in gallstones, early vs. chemical mediators in, 663
delayed, 509 complications of, 671-672
laparoscopic, 511-512 differential diagnosis of, 664-668
open, 511 environmental factors in, 661-662
Cholecystitis, acute, from gallstones, 502- historical perspectives of, 658-659
504 immune responses in, 664
Cholecystography, in gallstones, 506-507 laboratory studies in, 668-669
Cholecystolitholysis, percutaneous, 510 pathogenesis of, 661-662
Choiedocholithiasis, 504 pathology of, 662
Cholera, diarrhea in, 633-634 persistent cough in, 884, 886-887
epidemic of (France, 1830s), paradigm prevention of, 672
shift from, 192-194 treatment of, 670-671
Cholestasis, hyperbilirubinemia in, 559 viruses causing, 659-661
pruritus in, 467-468 Communication, humor in, 144
Cholestyramine, in diarrhea, 642 in telephone care, 93-94
in irritable bowel syndrome, 485 with homosexual persons, 43
Ciprofloxacin, in diarrhea, 643 Community-oriented care, 1-15
in inflammatory bowel disease, 588 case studies in, 8-10
Cirrhosis, biliary, vs. hepatitis C, 543 collaboration with community in, 9-10
Cisapride, in gastroesophageal reflux dis- community definition in, 4-7
ease, 438, 572-573 definition of, 2-4
in irritable bowel syndrome, 486 evaluation of, 8, 13
Clarithromycir. 1 Helicobacter pylori infec- functional elements of, 3-4
tions, 450 future of, 13-14
in inflammatory bowel disease, 588 history of, 1-2
in otitis media, 681-682 in health maintenance organizations, 11
in pharyngitis, 730 interventions in, 7
in sinusitis, 712 obstacles to, 12-13
Clavicle, fractures of, 384-385 primary care practice component of, 4
Claw toe deformity, 211 priority needs identification in, 7
Clindamycin, in otitis media, 683 process for, 4-8
in pharyngitis, 730 structural elements of, 3-4
Clonidine, in diarrhea, 644 teen pregnancy focus of, 9
Codman’s exercises, 400-401 Compartment syndrome, exertional, 278
Cognitive-behavioral therapy, in irritable in rehabilitation, 337
bowel syndrome, 488 Compression, in rehabilitation, 337
Colchicine, in gouty arthritis, 234 Compression fractures, of spine, 358
Cold, common. See Common cold. Computed tomography, in back pain, 352
CUMULATIVE INDEX 1996 897
Conditioning program, in rehabilitation, C-reactive protein, measurement of, in
338 pneumonia, 824
Condyloma acuminata, 617-618 Crigler-Najjar syndrome, hyperbilirubine-
Constipation, in irritable bowel syndrome, mia in, 558-559
477 Crime, against homosexual persons, 38-39
treatment of, 486 Crohn disease, cutaneous manifestations
Consultations, in Home Visit Program, 57- of, 464
58 treatment of. See Inflammatory bowel dis-
Contact dissolution, of gallstones, 510 ease, treatment of.
Contrast baths, in rehabilitation, 336-337 Croup, bacterial, 774-779
Coping, humor in. See Humor. definition of, 761-762
Copper, metabolic disorders of, in Wilson’s viral, 762-774
disease, vs. hepatitis C, 541-542 clinical features of, 764
Corn, soft, 203-204 diagnosis of, 764-765
Coronavirus infections, common cold, 659- differential diagnosis of, 764
660, 664-667 epidemiology of, 762-763
Corticosteroids, in arthritis, 224 microbiology of, 764
gouty, 234 monitoring of, 766
rheumatoid, 231 recurrent, 763-764
in croup, 767-772 spasmodic, 763-764
in inflammatory bowel disease, 582, 585- treatment of, 766-773
586 Cryoglobulinemia, in hepatitis B, 470
in sinusitis, 713-714 in hepatitis C, 471-472
Corynebacterium infections, pharyngitis in, Culture, blood, in pneumonia, 824-825
733 Helicobacter pylori, 445
Cost issues, 115-126 in pertussis, 795
advance directives and, 75-76 throat, in pharyngitis, 727-728
containment versus quality, 122-123 Cumulative trauma disorder. See Overuse
cost versus charges, 116-117 syndromes.
cost-effectiveness, 118-119 Cutaneous manifestations, in gastrointesti-
analysis of, 121-122 nal disease, 455-476
perspectives on, 120-121 bleeding, 459-464
economies of scale, 117-118 cancer, 465-467
in primary care specialty choice, 160-161 inflammatory bowel disease, 464
in telephone care, 88-89 liver, 467-473
paradigm shift from, 197-198 pancreatic, 467
quality management and, 122-123 polyposis, 455-458
Cyclobenzaprine, as muscle relaxant, 329-
quality of life and, 120
332
terminology of, 123-125
Cyclosporine, in inflammatory bowel dis-
Cost-benefit analysis, 118
ease, 594-596
Cost-minimization analysis, 118
Cystic fibrosis, persistent cough in, 885
Cough, in gastroesophageal reflux disease,
Cytogenic analysis, of soft-tissue tumors,
564, 568
253-254
in pneumonia, 823
Cytomegalovirus infections, pharyngitis in,
persistent, in children, 883-892
724
case study of, 883-884
pneumonia, 841, 852-853
evaluation of, 884-886
history of, 887-889
pathophysiology of, 886-887 Dancer's pad, in running and walking inju-
physical examination in, 889-890 ries, 269
psychogenic, 886 de Quervain’s syndrome, 310-311
treatment of, 890-891 Death, advance directives and. See Advance
in gastroesophageal reflux disease, directives.
434-435 Decongestants, in common cold, 670-671
Cowden disease, cutaneous manifestations in sinusitis, 713
of, 456-457 Degos disease, 462-464
Coxsackievirus infections, common cold, Dental erosions, in gastroesophageal reflux
666-667 disease, 565, 568
pharyngitis, 724 Dermatologic disorders, of foot, 203-205
898 CUMULATIVE INDEX 1996
Diabetes, bronze, vs. hepatitis C, 543 diagnosis of, 565-566
Diabetes mellitus, foot problems in, 213- nonulcer, Helicobacter pylori and, 451
214 pathophysiology of, 562
in homeless population, 23-24 treatment of, 568-569
Diarrhea, 629-647 Dysphagia, 417-432
acute, vs. chronic, 635-636 causes of, esophageal, 427-431
clinical approach to, 635-638 oropharyngeal, 425-427
diagnostic tests for, 638-641 definition of, 417
dysmotility, 635 diagnostic studies in, 423-425
history of, 637-638 esophageal, 427-431
in irritable bowel syndrome, 477 evaluation of, 418-423
treatment of, 485-486 in epiglottitis, 743
inflammatory, 634-635 oropharyngeal, 425-427
large bowel vs. small bowel, 636-637 Dysphonia, in epiglottitis, 743
osmotic, 632, 634 Dyspnea, in epiglottitis, 743
osmotic gap in, 634
pathophysiology of, 631-635
secretory, 633-634, 643-644 Ear infections. See Otitis media.
treatment of, 641-644 Eating disorders, in homosexual persons,
vs. normal intestinal fluid balance, 630- 37
631 Echovirus infections, common cold, 666-—
Dicyclomine, in irritable bowel syndrome, 667
485 Economies of scale, 117-118
Diet, flatulence and, 625 Edema, control of, in rehabilitation, 336—
in gastroesophageal reflux disease, 438,
569 Education, client, in rehabilitation, 335-336
in inflammatory bowel disease, 598-599 for telephone care, 91-93, 99-102
in irritable bowel syndrome, 485 influencing primary care specialty
in pancreatitis, 532 choice, 158-159
Digital extensor tendons, overuse injury of, Ehlers-Danlos syndrome, gastrointestinal
312 bleeding in, 462
Diphenoxylate, in diarrhea, 642 Einstein, Albert, theories of, paradigm shift
Diphtheria, pharyngitis in, 733 from, 194
Diphtheria-tetanus-pertussis (DTP) vacci- Elastic bandages, in rehabilitation, 337
nation, 798-801 Elderly persons, attitudes of, toward ad-
Disc(s), intervertebral, anatomy of, 347-348 vance directives, 70-71
herniation of, 358-362 gastroesophageal reflux disease in, respi-
Discography, in back pain, 352 ratory complications of, 433-434
Dissolution, of gallstones, contact, 510 homosexual, 39-40
medical, 509 humor with, 151
Diversion colitis, treatment of, 597 Electrolyte transport, in intestine, 630-631
Diverticula, esophageal, dysphagia in, 427 ELISA (enzyme-linked immunosorbent as-
Documentation, for telephone care, 94-95 say), in hepatitis C diagnosis, 538-
Drawer test, of knee stability, 327 539
Drooling, in epiglottitis, 743 Emergency department, primary care in,
Drugs, abuse of, in homeless population, for homeless population, 20-21
health care access and, 21-22 Empyema, in pneumonia, 832
esophagitis from, 421 End-of-life care, advance directives and.
gastroesophageal reflux disease from, See Advance directives.
570 Endoscopy, in dysphagia, 424
hepatitis from, vs. hepatitis C, 541 in Helicobacter pylori infections, 444-446
in Home Visit Program, 58-60 Engel biophysiosocial model, of medicine,
DTP vaccination, 798-801 183-185
Durable power of attorney for health care, Enterovirus infections, pneumonia, 852
69-70 Entrapment neuropathy, of foot, 208
Dying, advance directives and. See Advance Enzyme immunoassays, for common cold
directives. viruses, 668-669
. Dysmotility diarrhea, 635 Enzyme-linked immunosorbent assay, in
Dyspepsia, 561-576 hepatitis C diagnosis, 538-539
definition of, 561-562 in pertussis diagnosis, 796
CUMULATIVE INDEX 1996 899
Epiglottitis, 736, 742-747 Flatfoot, 212
Epinephrine, in croup, 770-772 in pediatric patients, 299-300
Epstein-Barr virus infections, pharyngitis running injuries and, 264
in, 722-724 Flatulence, 624-625
Ergonomics, in overuse syndrome preven- Flexor tendinitis, of hand and wrist, 313-
tion, 308-309 317
Erythema, palmar, in liver disease, 469 Fluid balance, intestinal, 630-631
Erythema nodosum, in inflammatory Fluticasone, in inflammatory bowel disease,
bowel disease, 464 586
Erythrocyte sedimentation rate, in pneu- Folk remedies, for common cold, 671
monia, 824 Foot problems, 203-214. See also Ankle inju-
Erythromycin, in otitis media, 681-682 ries.
in pertussis, 797 Achilles tendon, 275, 293
Esophagitis, drug-induced, 421 anatomic considerations in, 264-266,
reflux, 564 282-283
Esophagogastroduodenoscopy, in gastro- biomechanics in, 264-266
esophageal reflux disease, 566 bunions, 293-297
Esophagography, in dysphagia, 423-424 dermatologic, 203-205
Esophagoscopy, in dysphagia, 424 forefoot, 268-272, 287-288
Esophagus, Barrett's, dysphagia in, 428 heel pain, 291-292
in gastroesophageal reflux disease, 565 history in, 266-268, 281-282
manometry of, in gastroesophageal re- in diabetes mellitus, 213-214
flux disease, 567 in pediatric patients, 299-301
sphincters of, dysfunction of, gastro- in running and walking, 263-280
esophageal reflux disease in, 562- leg pain in, 278
563 metatarsus adductus, 300
strictures of, dysphagia in, 428 musculoskeletal, 210-212
in gastroesophageal reflux disease, 565 neurologic, 208-210, 290-291
Ethambutol, in tuberculosis, 874-877 orthotics for, 278-279
Eustachian tube dysfunction, otitis media physical examination in, 266-268, 281-
in, 677-678, 688 297
Exercises, for ankle, 391-393
anatomic considerations in, 282-283
for knee, 395-397
dorsal, 285-286
for shoulder, 400-401
forefoot, 287-288
range of motion, 338-339
general, 283-284
strengthening, 340
hindfoot, 288-289
Exostosis, in foot, 212, 270
lateral, 284-285
Extensor tenosynovitis, of hand and wrist,
medial, 286-287
310-313
neurologic, 290-291
observation in, 283
Family, of homosexual persons, 32-33, 42-
range of motion, 289-290
43
Fasciitis, plantar, 273-274, 292 vascular, 291
Fatty acids, omega-3, in inflammatory plantar fasciitis, 273-274, 292
bowel disease, 597 rehabilitation in, 279
short chain, in inflammatory bowel dis- stress fractures, 277-278
ease, 597 tendinitis, 275-277
Fecal incontinence, 616-617 toe in and toe out, 300-301
Fedotozine, in irritable bowel syndrome, toenail abnormalities, 205-207
488 vascular, 207-208, 291
Fees, for telephone care, 86-87 Foucault, Michael, on perspective, 195-196
Femoral epiphysis, slipped, 302 Fractures, 405-409
Femoral version, foot position in, 300-301 insufficiency, of spine, 358
Fiber, dietary, in irritable bowel syndrome, of clavicle, 384-385
486 stress, in running and walking, 277-278
Finger, trigger, 314 Francisella tularensis infections, pharyngitis
Fissures, anal, 613-614 in, 734
Fistulas, anal, 615 Frustration, management of, humor in,
FK506 (tacrolimus), in inflammatory bowel 144-146
disease, 598 Fungal infections, of foot, 205-207
900 CUMULATIVE INDEX 1996
a-Galactosidase, for flatulence, 625 evaluation of, 436-437
Galen, influence of, 188-190 in elderly persons, 433-434
Gallstones, 497-513 treatment of, 437-439
acute cholecystitis in, 502-504 treatment of, 569-573
asymptomatic, 500-501 Gateway Service Center, homeless health
biliary colic in, 501-502, 508-509 care in, 27-28
bilirubin, 559 Gay men. See Homosexual persons.
cholangitis in, 504-506 Genu valgum, 301
choledocholithiasis in, 504 Genu varum, 301
classification of, 498 Gianotti-Crosti syndrome, in hepatitis B,
clinical manifestations of, spectrum of, 471
498-499 Gilbert syndrome, hyperbilirubinemia in,
clinical presentation of, 499-506 558
diagnosis of, 506-507 Glenohumeral joint, instability of, 381-384
differential diagnosis of, 499-500 a-globulins, measurement of, in liver dis-
epidemiology of, 497 ease screening, 556
pancreatitis in, 506, 530 B-globulins, measurement of, in liver dis-
treatment of, 499, 530 ease screening, 556-557
controversies in, 508-509 t-globulins, measurement of, in liver dis-
options for, 509-512 ease screening, 557
Gardner's syndrome, 455-456 Globus hystericus, 420
Gas syndromes, gastrointestinal, 621-628 Glomerulonephritis, poststreptococcal, 732
abdominal distention, 626-627 Glucagon, in pancreatitis, 529
belching, 622-624 Glucagonoma, cutaneous manifestations of,
flatulence, 624-625 466-467
gas pains, 627-628 Glucurony] transferase, deficiency of, hy-
in irritable bowel syndrome, 477 perbilirubinemia in, 558-559
incontinence in, 616-617 t-Glutamyl transpeptidase, measurement
Gastritis, Helicobacter pylori in, 444 of, in liver disease screening, 554
Gastroenterology, anal disease, 609-620 Gonococcal arthritis, 235-237
cancer. See also Colorectal cancer. Gonorrhea, anorectal, 619
cutaneous manifestations of, 465-467 pharyngitis in, 734
cutaneous manifestations of gastrointesti- Gouty arthritis, 232-234
nal disease, 455-476 Greek culture, health paradigms in, 186-
diarrhea, 477, 485-486, 629-647 188
dyspepsia, 451, 561-576 Group Health Cooperative of Puget Sound,
dysphagia, 417-432 11
gallstones, 497-513, 530, 559 Gynecologic disorders, in homosexual per-
gas syndromes, 477, 621-628 sons, 37
gastroesophageal reflux disease, 431,
433-441, 561-576
hepatitis C, chronic, 535-549 Haemophilus influenzae infections, epiglotti-
inflammatory bowel disease, 464, 577- tis in, 742-747
608 immunization for, 747
irritable bowel syndrome, 477-495 otitis media in, 679
liver disease. See Liver, disease of. Haglund’s deformity, 275
pancreatitis, 525-534 Hallux, deformities of, 211
peptic ulcer disease, 443-454 Hallux limitus, in running and walking,
Gastroesophageal reflux disease, 561-576 269-270
complications of, 563-565 Hallux rigidus, in running and walking,
definition of, 562 269-270
diagnosis of, 566-568 Hallux valgus (bunion), 293-297
dysphagia in, 431 Hammertoe, 210-211
pathophysiology of, 562-563 Hamstring stretch, 395-396
rebound, 572 Hand, overuse syndromes of. See Overuse
respiratory complications of, 433-441 syndromes, of hand and wrist.
acid laryngitis, 434 Health department, cooperation with, in
asthma, 434-435 tuberculosis, 878
chronic cough, 434-435 Health maintenance organizations, commu-
clinical features of, 435-436 nity-oriented care in, 11
CUMULATIVE INDEX 1996 901
preventive care in, 130-131 Hoarseness, in gastroesophageal reflux dis-
telephone use in, 87-89 ease, 564, 568
Health Plan Employer Data and Informa- Home Visit Program, 47-65
tion Set, in preventive care, 130-131 consultations generated in, 57-58
Hearing loss, in chronic otitis media, 693- demographics of, 50-53
695 diagnoses in, 54
Heart disease, in homeless population, 24 efficacy of, 62-64
Heartburn, in gastroesophageal reflux dis- goals of, 49-50
ease, 562, 567 history of, 48-50
Heel pain, 291-292 hospitalizations in, 55-57
Helicobacter pylori infections, 443-454 medications used in, 58-60
culture in, 445 screening in, 60-62
diagnosis of, 444-447 Homeless persons, 17-30
epidemiology of, 447-448 definition of, 17-18
histology of, 444445 description of, 18-19
nonulcer dyspepsia, 451 health problems of, 22-25
organism characteristics, 443-444 primary care of, barriers to, 19-22
pathogenesis of, 448 collaborative, 25-28
treatment of, 449-451 Homosexual persons, 31-46
Hemochromatosis, vs. hepatitis C, 543 adolescent, 39
Hemolysis, hyperbilirubinemia in, 558 aging and, 39-40
Hemorrhoids, 610-613 attitudes toward, 34-36, 41-42
Hepatic flexure syndrome, pain in, 627 communication with, 43
Hepatic triglyceride lipase, measurement definition of, 31-32
of, in liver disease screening, 556 demography of, 32-33
Hepatitis, autoimmune, vs. hepatitis C, essentialist view of, 33
540-541 families of, 32-33, 42-43
in homosexual persons, 36 health care for, improvement of, 41-44
Hepatitis A, cutaneous manifestations of, practice changes in, 43-44
470 preventive, 36
Hepatitis B, cutaneous manifestations of, health problems of, 36-39
470-471 HIV infections in, 36
vs. hepatitis C, 540 psychosocial considerations and, 37-38
Hepatitis C, chronic, 535-549 sexual orientation disclosure by, reac-
algorithm for, 546 tions to, 35-36
clinical features of, 537 social constructionist view of, 33-34
diagnosis of, 538-539 violence against, 38-39
differential diagnosis of, 540-543 Hospitalization, of Home Visit Program
laboratory features of, 538 participants, 55-57
risk factors for, 536-537 House call programs. See Home visit program.
treatment of, 543-545 Human immunodeficiency virus infection,
cutaneous manifestations of, 471-473 in homeless population, 23
Herniation, of intervertebral discs, 358-362 in homosexual persons, 36
Herpes simplex virus infections, anal, 618- Kaposi's sarcoma in, 244, 461
619 onychomycosis in, 206
pharyngitis in, 725 pathogenesis of, paradigms for, 185-186
Hip, arthritis of, evaluation of, 221 peripheral neuropathy in, 209
dislocation of, in pediatric patients, 301- pharyngitis in, 725
302 Pneumocystis carinii pneumonia in, 854
disorders of, rehabilitation in, 397-398 tuberculosis in, 875
exercises for, 397-398 Humeral head, osteonecrosis of, 381
function of, 397 Humidification, in croup, 767
slipped capital femoral epiphysis in, 302 Humor, in primary care, 141-154
Histamine, release of, in common cold, 663 importance of, 146-148
Histamine,2-blockers, in gastroesophageal learning to use, 151-152
reflux disease, 570-572 role of, 142-146
in pancreatitis, 529 therapeutic use of, 148-150
HIV infection. See Human immunodeficiency with adolescents, 150-151
virus infection. with children, 150
902 CUMULATIVE INDEX 1996
Humor (continued) Inflammatory diarrhea, 634-635
with older patients, 151 Influenza virus, in common cold, 659-660,
Hydration, in croup, 767 667-668
Hygeia, representing public health, 186 in pharyngitis, 725
Hyoscyamine, in diarrhea, 642 in pneumonia, 840
in irritable bowel syndrome, 485 Infraglottic infections, 759-791
Hyperalgesia, visceral, in irritable bowel anatomic considerations in, 760
syndrome, 480 classification of, 761
Hyperbilirubinemia, cutaneous manifesta- croup, 762-774
tions of, 468 defenses against, 760
detection of, in liver disease, 557-559 pathophysiology of, 760-761
Hyperkeratosis, of foot, 203-204 terminology of, 761-762
Hypermelanosis, in liver disease, 469 tracheitis, 774-779
Hypertension, biofeedback in, 177 Ingrown toenail, 206-207
in homeless population, 23 Interferon-a, in hepatitis C, 543-545
relaxation training in, 175-176 Interferon(s), in common cold pathogene-
Hyperuricemia, gouty arthritis in, 232-234 sis, 663
Hypnosis, 177 in common cold treatment, 670
Hypnotherapy, in irritable bowel syn- Interpersonal gaps, narrowing of, humor
drome, 489 in, 142-143
Intersection syndrome, in wrist overuse,
311-312
Ice, in edema control, 336 Intervertebral discs, anatomy of, 347-348
Immune response, in bronchiolitis, 808-809 herniation of, 358-362
in common cold, 664 Intestine, fluid balance in, 630-631
Immune system, behavioral effects on, 170- lodoquinol, in diarrhea, 643
171 Irritable bowel syndrome, 477-495
in cancer, 173-174 clinical evaluation of, 481-483
nervous system interactions with, 171-172 definition of, 477
psychological effects on, 172-173 diagnostic criteria for, 478
Immunization, Haemophilus influenzae, 747 epidemiology of, 478-479
in Home Visit Program, 62 gas pain in, 627
pertussis, 797-801 pathogenesis of, 479-481
Immunodeficiency, persistent cough in, 885 treatment of, 484-491
Immunofluorescence test, in pertussis, 795- behavioral, 488-489
796 dietary, 485
Immunosuppressive therapy, in inflamma- drugs in, 485-488
tory bowel disease, 588-596 physician-patient relationship in, 484-
Impingement maneuvers, in shoulder eval- 485
uation, 368-370 psychological, 488-489
Impingement syndrome, of shoulder, 376- with mild symptoms, 489-490
378 with moderate symptoms, 490
Incontinence, fecal, 616-617 with severe symptoms, 491
Infectious mononucleosis, pharyngitis in, Isoniazid, in tuberculosis, 874-877
722-724 Itching, anal, 615-616
Inflammatory bowel disease, cutaneous
manifestations of, 464
treatment of, 577-608 Jaundice, in liver disease, 468
aminosalicylates in, 577-584 Joint(s), inflammation of. See Arthritis.
antibiotics in, 586-588 protection of, in rehabilitation, 337-338
corticosteroids in, 582, 585-586 Jokes. See Humor.
goals of, 577
immunosuppressants in, 588-596 Kaposi's sarcoma, 460-461
in Crohn disease, 601-602 in HIV infection, 244
in left-sided colitis, 601 Kawasaki disease, pharyngitis in, 735
in pancolitis, 601 Kidney, streptococcal pharyngitis effects
in proctitis, 600 on, 732
in ulcerative colitis, 600-601 Knee, anatomy of, 321-322
novel agents for, 597-598 angular deformities of, 301
nutrition in, 598-599 arthritis of, evaluation of, 221